While it is very hard to create a study showing that a successful drug does not work, it can be done, with the right people and funding. This appears to have happened in a paper published June 28 by a group of latin american and US authors.
Ivermectin studies were cherrypicked to yield a poor outcome. This is no easy task, since virtually all of the 60 studies in existence show positive benefits.
Here is the new study that was designed to sink ivermectin treatment of Covid. It was published by Oxford University Press, for the IDSA (the organization that has covered up chronic Lyme disease for over 30 years):
Among the authors are people who you would not expect to be studying ivermectin.
The authors include an employee of Cello Health, the Centro de Investigación, Instituto Peruano de Oncología y Radioterapia (IPOR), and the Unidad de revisiones sistemáticas y meta-análisis, guías de práctica clínica y evaluaciones de tecnologías sanitarias (URSIGET). The last 2 are in Peru.
Cello Health is a high end consulting company, mostly to Pharma. It claims to work with 24 of the top 25 pharma companies in the world. Its website brags about “Competitor Planning and Response.” One of its consulting jobs is “supporting the Scottish Government in the creation of a series of compelling public health campaigns to drive social distancing and self-isolation…”
IPOR is a cancer treatment center in Lima, Peru. Its long list of partners includes the NIH and many large pharmaceutical companies. When you open the website you see a pop-up offering vaccinations.
URSIGET, as best I can tell, is a Peruvian organization designed to help train scientists how to write papers and get research grants.
All 3 of these organizations have a focus on consulting and making money. The authors are not academics. Yet the paper claims:
Funding: No funding was received for this study.
Conflict of Interest: The authors declare that there is no conflict of interest.
Do you believe it? I don’t. This looks like another form of paid hit job, grossly similar to the Colombian paper dissing ivermectin I wrote about 4 months ago. It was probably farmed out to a foreign country to make its financial trail harder to identify.
It has been criticized by Tess Lawrie and Pierre Kory’s groups. Here is a compilation of 60 ivermectin studies so you can compare the overall results with those of this paper.
Here is the Roman/Peruvian paper’s abstract: